Goldman Sachs’s Cytosorbents Corp CTSO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$59.9K Sell
46,796
-15,866
-25% -$20.3K ﹤0.01% 4952
2025
Q1
$62.7K Buy
62,662
+37,519
+149% +$37.5K ﹤0.01% 4888
2024
Q4
$22.9K Buy
+25,143
New +$22.9K ﹤0.01% 4899
2023
Q2
Sell
-15,365
Closed -$51.8K 4970
2023
Q1
$51.8K Buy
+15,365
New +$51.8K ﹤0.01% 4761
2022
Q4
Sell
-11,618
Closed -$16K 5183
2022
Q3
$16K Sell
11,618
-44,096
-79% -$60.7K ﹤0.01% 5199
2022
Q2
$122K Sell
55,714
-243,163
-81% -$532K ﹤0.01% 5061
2022
Q1
$954K Buy
298,877
+168,712
+130% +$539K ﹤0.01% 4136
2021
Q4
$546K Buy
130,165
+43,115
+50% +$181K ﹤0.01% 4455
2021
Q3
$707K Sell
87,050
-3,842
-4% -$31.2K ﹤0.01% 4191
2021
Q2
$686K Buy
90,892
+22,631
+33% +$171K ﹤0.01% 4250
2021
Q1
$593K Sell
68,261
-201,501
-75% -$1.75M ﹤0.01% 4243
2020
Q4
$2.15M Buy
269,762
+70,967
+36% +$566K ﹤0.01% 3026
2020
Q3
$1.59M Buy
198,795
+11,407
+6% +$91K ﹤0.01% 3036
2020
Q2
$1.86M Buy
187,388
+111,713
+148% +$1.11M ﹤0.01% 2875
2020
Q1
$585K Buy
75,675
+34,176
+82% +$264K ﹤0.01% 3410
2019
Q4
$160K Buy
41,499
+27,985
+207% +$108K ﹤0.01% 4035
2019
Q3
$68K Buy
13,514
+2,641
+24% +$13.3K ﹤0.01% 4097
2019
Q2
$72K Sell
10,873
-3,052
-22% -$20.2K ﹤0.01% 4051
2019
Q1
$105K Sell
13,925
-18,606
-57% -$140K ﹤0.01% 4008
2018
Q4
$262K Buy
32,531
+9,006
+38% +$72.5K ﹤0.01% 3646
2018
Q3
$303K Buy
23,525
+13,044
+124% +$168K ﹤0.01% 3664
2018
Q2
$119K Sell
10,481
-31,532
-75% -$358K ﹤0.01% 3983
2018
Q1
$296K Buy
42,013
+19,492
+87% +$137K ﹤0.01% 3709
2017
Q4
$146K Buy
+22,521
New +$146K ﹤0.01% 3892
2016
Q1
Sell
-22,941
Closed -$128K 4504
2015
Q4
$128K Buy
22,941
+3,691
+19% +$20.6K ﹤0.01% 3916
2015
Q3
$121K Buy
+19,250
New +$121K ﹤0.01% 4094